HCW BIOLOGICS INC (HCWB) Forecast, Price Target & Analyst Ratings
NASDAQ:HCWB • US40423R2040
0.56 USD
-0.03 (-5.08%)
Last: Mar 10, 2026, 11:41 AM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for HCW BIOLOGICS INC (HCWB).
Forecast Snapshot
Consensus Price Target
$8.16
+ 1,357.14% Upside
Next Earnings Forecast
Release DateN/A
PeriodQ4 / 2025
EPS Estimate-$0.86
Revenue Estimate
ChartMill Buy Consensus
82.86%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$8.16
Upside
+ 1,357.14%
From current price of $0.56 to mean target of $8.16, Based on 7 analyst forecasts
Low
$8.08
Median
$8.16
High
$8.40
Price Target Revisions
1 Month
0.00%
3 Months
-77.14%
Price Target Summary
7 Wall Street analysts provided a forecast for the next 12 months for HCWB. The average price target is 8.16 USD. This implies a price increase of 1357.14% is expected in the next year compared to the current price of 0.56.
The average price target has been revised downward by 77.14% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
82.86%
HCWB was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about HCWB.
In the previous month the buy percentage consensus was at a similar level.
HCWB was analyzed by 7 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-05-29 | Maxim Group | Maintains | Buy -> Buy |
| 2023-04-19 | EF Hutton | Reiterate | Buy |
| 2023-03-30 | EF Hutton | Reiterate | Buy |
| 2023-03-23 | EF Hutton | Reiterate | Buy |
| 2022-11-08 | JonesTrading | Initiate | Buy |
| 2021-11-19 | EF Hutton | Initiate | Buy |
Next Earnings Forecast Details
Next Earnings Details
Release DateN/A
PeriodQ4 / 2025
EPS Estimate-$0.86
Revenue Estimate
Revenue Q2Q-100.00%
EPS Q2Q73.23%
Number of Analysts3
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
65.43%
Next Earnings Summary
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 6.72M | 2.842M -57.71% | 2.567M -9.68% | 27.54K -98.93% | -100.00% | 163.72M | 378.05M 130.91% | 642.3M 69.90% | ||
| EBITDA YoY % growth | -14.36M -11.93% | -24.582M -71.18% | -27.768M -12.96% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -15.08M -12.79% | -25.717M -70.54% | -28.952M -12.58% | -12.433M 57.06% | -17.775M -42.96% | -20.417M -14.87% | 66.189M 424.18% | 236.23M 256.90% | 441.01M 86.69% | |
| Operating Margin | -224.40% | -904.96% | -1,127.96% | -45,144.44% | N/A | N/A | 40.43% | 62.49% | 68.66% | |
| EPS YoY % growth | -16.80 46.17% | -28.00 -66.67% | N/A 16.94% | -5.33 77.06% | -1.17 78.01% | -0.97 17.39% | -2.28 -135.79% | -2.47 -8.04% | N/A |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.86 73.23% | -0.45 | -1.03 4.61% | -1.12 44.46% | -1.16 -35.71% |
| Revenue Q2Q % growth | -100.00% | -100.00% | N/A | N/A | N/A |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -3.536M -34.46% | -4.088M -141.52% | -4.456M -32.56% | -4.828M -47.34% | -5.013M -41.77% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
25.11%
EPS Next 5 Year
13.62%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
-25.99%
Revenue Next 5 Year
109.56%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
HCW BIOLOGICS INC / HCWB Forecast FAQ
What do analysts expect the price target to be for HCW BIOLOGICS INC (HCWB)?
7 analysts have analysed HCWB and the average price target is 8.16 USD. This implies a price increase of 1357.14% is expected in the next year compared to the current price of 0.56.
What are the consensus estimates for HCW BIOLOGICS INC (HCWB) next earnings?
The consensus EPS estimate for the next earnings of HCW BIOLOGICS INC (HCWB) is -0.86 USD and the consensus revenue estimate is 0 USD.
Can you provide the expected long term growth rate for HCW BIOLOGICS INC stock?
The expected long term growth rate for HCW BIOLOGICS INC (HCWB) is -25.99%.